View Older Stories View More Recent Stories

Jul 27, 2023 07:00AM Novocure Reports Second Quarter 2023 Financial Results
Jul 22, 2023 09:30AM ROSEN, NATIONAL TRIAL COUNSEL, Encourages NovoCure Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action – NVCR
Jul 21, 2023 08:00AM Novocure (NVCR) Reports Favorable Independent Data Monitoring Committee Recommendation to Continue Phase 3 PANOVA-3 Trial of Tumor Treating Fields Therapy in Pancreatic Cancer
Jul 21, 2023 08:00AM Novocure Announces Favorable Independent Data Monitoring Committee Recommendation to Continue Phase 3 PANOVA-3 Clinical Trial of Tumor Treating Fields Therapy in Pancreatic Cancer
Jul 3, 2023 08:00AM Novocure to Report Second Quarter 2023 Financial Results
Jun 6, 2023 08:07AM Zai Lab (ZLAB) and Novocure (NVCR) Report LUNAR Phase 3 Trial Demonstrates Statistically Significant and Clinically Meaningful Extension in Overall Survival
Jun 6, 2023 08:05AM Zai Lab and Novocure Announce LUNAR Phase 3 Clinical Trial Demonstrates Statistically Significant and Clinically Meaningful Extension in Overall Survival for Patients with Metastatic Non-Small Cell Lu
Jun 6, 2023 08:00AM Novocure (NVCR) Reports LUNAR Phase 3 Clinical Trial Demonstrates Statistically Significant and Clinically Meaningful Extension in Overall Survival for Patients with Metastatic Non-Small Cell Lung Can
Jun 6, 2023 08:00AM LUNAR Phase 3 Clinical Trial Demonstrates Statistically Significant and Clinically Meaningful Extension in Overall Survival for Patients with Metastatic Non-Small Cell Lung Cancer After Platinum-Based
Jun 1, 2023 07:01AM Novocure Pledges $3 Million to Conquer Cancer®, the ASCO Foundation, to Support Cancer Research and Education
May 4, 2023 07:00AM Novocure Reports First Quarter 2023 Financial Results
Apr 26, 2023 10:01AM Novocure Announces Presentation of Results of the LUNAR Phase 3 Clinical Trial in Non-Small Cell Lung Cancer at 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
Apr 14, 2023 08:27AM Novocure Announces 27 Presentations, Including Real-World Evidence and Preclinical Research, at American Association for Cancer Research (AACR) Annual Meeting 2023
Apr 3, 2023 08:00AM Novocure to Report First Quarter 2023 Financial Results
Mar 29, 2023 07:31AM Novocure (NVCR) Appoints Kristin Stafford to its Board
Mar 29, 2023 07:30AM Kristin Stafford Joins Novocure Board of Directors
Mar 28, 2023 08:00AM Virtual Incision Expands Leadership Team as it Prepares for New Market Growth
Mar 16, 2023 07:30AM Novocure Announces 5th Annual AACR-Novocure Grants for Tumor Treating Fields Research Program
Mar 1, 2023 07:01AM Novocure Announces Reimbursement of Optune® for the Treatment of Newly Diagnosed Glioblastoma in France
Mar 1, 2023 07:00AM Novocure Announces Last Patient Enrolled in Pivotal METIS Study of Tumor Treating Fields in Brain Metastases from Non-Small Cell Lung Cancer
Feb 23, 2023 07:06AM Novocure (NVCR) Appoints Allyson J. Ocean to its Board
Feb 23, 2023 07:00AM Allyson J. Ocean, M.D., Joins Novocure Board of Directors
Feb 23, 2023 07:00AM Novocure Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Company Update
Feb 15, 2023 07:00AM Novocure Announces Last Patient Enrolled in Pivotal PANOVA-3 Study of Tumor Treating Fields in Pancreatic Cancer
Jan 19, 2023 07:32AM Novocure (NVCR) Announces Organizational Changes
Jan 19, 2023 07:30AM Novocure Announces Organizational Changes to Prepare for Future Growth
Jan 9, 2023 07:00AM Novocure Announces Preliminary Full Year and Fourth Quarter 2022 Net Revenues and Provides Company Update
Jan 5, 2023 07:35AM Zai Lab Limited (ZLAB) and Novocure (NVCR) Announce LUNAR Study Met Primary Overall Survival Endpoint
Jan 5, 2023 07:34AM Zai Lab and Novocure Announce Pivotal LUNAR Study in Non-Small Cell Lung Cancer Met Primary Overall Survival Endpoint
Jan 5, 2023 07:34AM Zai Lab and Novocure Announce Pivotal LUNAR Study in Non-Small Cell Lung Cancer Met Primary Overall Survival Endpoint
Jan 5, 2023 07:05AM Novocure (NVCR) Announces Pivotal LUNAR Study in Non-Small Cell Lung Cancer Met Primary Overall Survival Endpoint
Jan 5, 2023 07:00AM Novocure Announces Pivotal LUNAR Study in Non-Small Cell Lung Cancer Met Primary Overall Survival Endpoint
Dec 27, 2022 08:00AM Novocure to Participate in 41st Annual J.P. Morgan Healthcare Conference
Nov 29, 2022 08:00AM Novocure’s Optune® Approved in Canada for the Treatment of Newly Diagnosed and Recurrent Glioblastoma
Nov 23, 2022 08:00AM Novocure to Participate in 34th Annual Piper Sandler Healthcare Conference
Nov 17, 2022 08:00AM Novocure Announces 25 Abstracts on Tumor Treating Fields Therapy at Society for Neuro-Oncology 2022 Annual Meeting
Nov 15, 2022 08:00AM Novocure Opens Office in Montreal to Expand and Support Growing Business in Canada
Nov 11, 2022 08:01AM Novocure (NVCR) Secures CE Mark for New Array
Nov 11, 2022 08:00AM Novocure Secures CE Mark for New Array
Oct 27, 2022 07:09AM Novocure Reports Third Quarter 2022 Financial Results
Oct 21, 2022 06:03PM Novocure Announces 11 Presentations on Tumor Treating Fields in Multiple Solid Tumor Types at the American Society for Radiation Oncology 2022 Annual Meeting
Oct 20, 2022 09:21AM Novocure (NVCR) Announces Review Article of Anti-Cancer Mechanisms of Action of Tumor Treating Fields Published in JMCB
Oct 20, 2022 09:21AM Novocure Announces Review Article of Anti-Cancer Mechanisms of Action of Tumor Treating Fields Published in Journal of Molecular Cell Biology
Oct 20, 2022 09:16AM Novocure Launches Campaign to Drive Awareness and Understanding of Tumor Treating Fields Therapy
Oct 3, 2022 08:00AM Novocure to Report Third Quarter 2022 Financial Results
Sep 21, 2022 08:00AM Novocure Announces Creation of U.S. CNS Cancers Franchise Intended to Renew Focus on Growth in Glioblastoma Business
Aug 31, 2022 08:00AM Novocure to Participate in Upcoming Investor Conferences
Aug 10, 2022 08:00AM Novocure Hosts U.S. Sen. Maggie Hassan at Company’s Portsmouth Facility
Jul 28, 2022 07:00AM Novocure Reports Second Quarter 2022 Financial Results
Jul 27, 2022 08:00AM Novocure Announces Recipients of 4th Annual AACR-Novocure Grants for Tumor Treating Fields Research Program
View More Recent Stories View Older Stories